Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation (By similarity). Zusätzlich bieten wir Ihnen MELK Kits (24) und MELK Proteine (10) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 142 products:
Human Monoclonal MELK Primary Antibody für ICC, FACS - ABIN969538
Nakano, Joshi, Visnyei, Hu, Watanabe, Lam, Wexler, Saigusa, Nakamura, Laks, Mischel, Viapiano, Kornblum: Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. in Neuro-oncology 2011
Show all 2 Pubmed References
Human Polyclonal MELK Primary Antibody für ELISA, WB - ABIN263108
Nagase, Seki, Ishikawa, Tanaka, Nomura: Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1. in DNA research : an international journal for rapid publication of reports on genes and genomes 1996
Human Polyclonal MELK Primary Antibody für - ABIN2017585
Hu, Ru, Xiao, Chaturbedi, Hoa, Tian, Zhang, Ke, Yan, Nelson, Li, Gramer, Yu, Siegel, Zhang, Jia, Jadus, Limoli, Linskey, Xing, Zhou: Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. in PLoS ONE 2013
Human Polyclonal MELK Primary Antibody für WB - ABIN2475560
Niesler, Myburgh, Moore: The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. in Experimental physiology 2007
Show all 2 Pubmed References
MELK is a host factor required for optimal uncoating of the HIV-1 core to promote viral cDNA synthesis.
Here, the authors report that mutagenizing MELK with CRISPR/Cas9 has no effect on the fitness of basal breast cancer cell lines or cell lines from six other cancer types. Cells that harbor null mutations in MELK exhibit wild-type doubling times, cytokinesis, and anchorage-independent growth.
MELK-inhibitor has a role in triple-negative breast cancer cells demonstrating context-dependent response with p53 (zeige TP53 Antikörper) as a key determinant
MELK is an oncogenic kinase involved in the pathogenesis and recurrence of hepatocellular carcinoma.
Inhibition or depletion of MELK reduced cell proliferation and anchorage-dependent and -independent growth in various ovarian cancer cell lines through a G2/M cell cycle arrest, eventually resulting in apoptosis.
Report IL11RA (zeige IL11RA Antikörper) and MELK amplification in gastric cancer cell lines and primary gastric adenocarcinomas.
MELK expression in hepatocellular carcinoma is extremely intense compared to its expression reported in other types of cancer and could be a promising effective tumor marker of HCC (zeige FAM126A Antikörper).
targeting MELK by the inhibition of both its catalytic activity and its protein stability might sensitize tumours to DNA-damaging agents or radiation therapy by lowering the DNA-damage threshold
Together, these data indicate that MELK is a normally non-essential kinase, but is critical for basal-like breast cancer.
EZH2 (zeige EZH2 Antikörper) protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1 (zeige FOXM1 Antikörper)-dependent manner
MELK promotes cell migration and invasion via the FAK (zeige PTK2 Antikörper)/Paxillin (zeige PXN Antikörper) pathway, and plays an important role in the occurrence and development of gastric cancer.
Phosphorylation of the activation loop of MPK38 induces its movement resulting in kinase activation.
These results indicate that Trx (zeige TXN Antikörper) functions as a physiological inhibitor of MPK38, which plays an important role in inducing ASK1 (zeige MAP3K5 Antikörper)-, TGF-beta (zeige TGFB1 Antikörper), and p53 (zeige TP53 Antikörper)-mediated activity
an important role for MPK38-mediated phosphorylation of PDK1 (zeige PDPK1 Antikörper) in the negative regulation of PDK1 (zeige PDPK1 Antikörper) activity.
MPK38 may act as a novel regulator for promoting p53 (zeige TP53 Antikörper) activity through direct phosphorylation of p53 (zeige TP53 Antikörper) at Ser (zeige SIGLEC1 Antikörper)(15).
Upregulation of maternal embryonic leucine zipper kinase is associated with mammary tumor.
MELK is necessary for proliferation of embryonic and postnatal MNP and suggest that it regulates the transition from GFAP (zeige GFAP Antikörper)-expressing progenitors to rapid amplifying progenitors in the postnatal brain.
The characterization of two novel E2F (zeige E2F1 Antikörper) target genes, chromosome condensation-related SMC-associated protein 1 (Cnap1 (zeige NCAPD2 Antikörper)) and maternal embryonic leucine zipper kinase (Melk) is reported.
MPK38 physically interacts with ASK1 (zeige MAP3K5 Antikörper) in vivo and acts as a positive upstream regulator of ASK1 (zeige MAP3K5 Antikörper)
Melk-like gene may play a role in primitive hematopoiesis by affecting the expression of genes critical for hematopoiesis.
Overexpression of xMELK leads to failure of cytokinesis and impairs accumulation RhoA- a pivotal regulator of cytokinesis.
These results demonstrate the presence of a mitochondrial targeting signal at the N-terminus of the MC domain of MELK. This mitochondrial targeting signal was also functional in human HeLa cells.[MELK]
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation (By similarity). Also plays a role in primitive hematopoiesis, possibly by affecting the expression of genes critical for hematopoiesis.
maternal embryonic leucine zipper kinase
, maternal embryonic leucine zipper kinase-like
, pEg3 kinase
, protein kinase Eg3
, protein kinase PK38
, tyrosine-protein kinase MELK
, Protein kinase Eg3